Coronary bypass surgery, also known as coronary artery bypass grafting (CABG), is a medical procedure designed to address restricted blood flow to the heart muscle, primarily caused by the buildup of fatty deposits in the coronary arteries, known as atherosclerosis. This condition can lead to diminished blood supply to the heart, resulting in symptoms such as angina or, in severe cases, a heart attack. During the surgery, a skilled cardiac surgeon utilizes grafts of blood vessels, typically harvested from the patient's leg or chest, to create alternative pathways for blood to flow, bypassing the obstructed coronary arteries. The primary goal is to restore optimal blood circulation, alleviate symptoms, and enhance overall heart function. Coronary bypass surgery is typically recommended when other treatment options, such as medication or lifestyle changes, prove insufficient in managing coronary artery disease. While it involves a significant surgical procedure, ongoing advancements in medical technology and surgical techniques continue to improve the safety and success rates associated with this crucial intervention.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya